Lanton Law
Home
About
Practice Areas
Legal Services
Lobbying
Blog
Contact
Lanton Law
Home
About
Practice Areas
Legal Services
Lobbying
Blog
Contact

Lanton Law Blog

Learn about the latest trends and activities through our blog posts.

Lanton Law Talks to Applied Clinical Trials About The Hidden Impact of Drug Pricing on Government Clinical Trials

In part one of this video interview, Ron Lanton III, Esq., partner, Lanton Law, discusses how a potential increase in drug costs could affect the clinical research industry. The interview can be seen here.

clinical research, clinical trials, HHS, healthcareRon LantonJune 7, 2025Clinical trials, drug prices, rebates, HHS, government sponsored clinical trials
0 Likes
Previous

Lanton Law Talks to Applied Clinical Trials About How FDA Cuts Are Creating New Bottlenecks in Clinical Operations

clinical research, clinical trials, FDA, healthcare, HHSRon LantonJune 7, 2025Clinical trials, FDA, R&D, inspections, supply chain
Next

Bipartisan Bill Aimed At Expanding CMS Coverage Of Rx Digital Therapeutics Re-Introduced

digital health, Digital Therapeutics, healthcare, technology, telecommunications, telehealthRon LantonMay 14, 2025The Access to Prescription Digital Therapeutics Act of 2025, digital therapeutics